Plaque vulnerability and adverse outcomes: The long road to fight atherosclerosis
- PMID: 32329065
- DOI: 10.1111/eci.13253
Plaque vulnerability and adverse outcomes: The long road to fight atherosclerosis
Comment on
-
Exploring the role of extracellular matrix proteins to develop biomarkers of plaque vulnerability and outcome.J Intern Med. 2020 May;287(5):493-513. doi: 10.1111/joim.13034. Epub 2020 Mar 3. J Intern Med. 2020. PMID: 32012358 Review.
References
REFERENCES
-
- Holm Nielsen S, Jonasson L, Kalogeropoulos K, et al. Exploring the role of extracellular matrix proteins to develop biomarkers of plaque vulnerability and outcome. J Intern Med. 2020;287(5):493-513.
-
- Montecucco F, Lenglet S, Gayet-Ageron A, et al. Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke. Stroke. 2010;41(7):1394-1404.
-
- Carbone F, Burger F, Roversi G, et al. Leptin/adiponectin ratio predicts poststroke neurological outcome. Eur J Clin Invest. 2015;45(11):1184-1191.
-
- Carbone F, Satta N, Montecucco F, et al. Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes. Eur J Clin Invest. 2016;46(9):805-817.
-
- Bonaventura A, Mach F, Roth A, et al. Intraplaque expression of C-reactive protein predicts cardiovascular events in patients with severe atherosclerotic carotid artery stenosis. Mediators Inflamm. 2016;2016:9153673.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical